Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 09, 2021

SELL
$34.41 - $44.03 $6.67 Million - $8.53 Million
-193,708 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$37.29 - $47.19 $574,676 - $727,245
-15,411 Reduced 7.37%
193,708 $7.43 Million
Q4 2020

Jan 19, 2021

SELL
$34.3 - $44.09 $889,467 - $1.14 Million
-25,932 Reduced 11.03%
209,119 $9.15 Million
Q3 2020

Nov 16, 2020

SELL
$27.86 - $39.35 $553,633 - $781,963
-19,872 Reduced 7.8%
235,051 $9.25 Million
Q2 2020

Jul 17, 2020

SELL
$30.3 - $42.55 $4.07 Million - $5.72 Million
-134,432 Reduced 34.53%
254,923 $8.04 Million
Q1 2020

Apr 16, 2020

SELL
$30.0 - $54.18 $288,990 - $521,915
-9,633 Reduced 2.41%
389,355 $13.7 Million
Q4 2019

Feb 14, 2020

SELL
$42.29 - $52.2 $1.66 Million - $2.05 Million
-39,250 Reduced 8.96%
398,988 $19.4 Million
Q3 2019

Nov 14, 2019

SELL
$42.06 - $51.64 $1.37 Million - $1.69 Million
-32,664 Reduced 6.94%
438,238 $20.8 Million
Q2 2019

Aug 14, 2019

SELL
$33.93 - $43.66 $6.69 Million - $8.61 Million
-197,318 Reduced 29.53%
470,902 $20.2 Million
Q1 2019

May 07, 2019

SELL
$26.74 - $41.32 $1.21 Million - $1.87 Million
-45,143 Reduced 6.33%
668,220 $25.8 Million
Q4 2018

Jan 25, 2019

SELL
$25.26 - $38.43 $863,462 - $1.31 Million
-34,183 Reduced 4.57%
713,363 $20.3 Million
Q3 2018

Oct 30, 2018

SELL
$33.27 - $39.25 $892,035 - $1.05 Million
-26,812 Reduced 3.46%
747,546 $29.3 Million
Q2 2018

Aug 03, 2018

SELL
$21.73 - $33.15 $288,878 - $440,696
-13,294 Reduced 1.69%
774,358 $25 Million
Q1 2018

Apr 30, 2018

SELL
$21.05 - $26.6 $72,980 - $92,222
-3,467 Reduced 0.44%
787,652 $17.3 Million
Q4 2017

Jan 18, 2018

SELL
$23.37 - $29.26 $409,559 - $512,781
-17,525 Reduced 2.17%
791,119 $18.7 Million
Q3 2017

Oct 31, 2017

BUY
$27.25 - $31.55 $22 Million - $25.5 Million
808,644
808,644 $22.8 Million

Others Institutions Holding CSII

About Cardiovascular Systems Inc


  • Ticker CSII
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 41,905,900
  • Description
  • Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...
More about CSII
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.